Shionogi Announces Publication of Two Studies in The Lancet Infectious Diseases Highlighting the Efficacy and Safety of FETROJA® for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options
Shionogi announces publication of data from two of its clinical trials; APEKS-NP and CREDIBLE-CR in…